Senate committee calls for cancer medicine review

17 September 2015 - A parliamentary committee probing access to expensive cancer drugs says a complete review of Australia's medicine system ...

Read more →

PBAC Public Summary Documents - March 2015

15 September 2015 - Two Public Summary Documents for nintedanib esylate from the March 2015 Pharmaceutical Benefits Advisory Committee (PBAC) meeting ...

Read more →

Pharmaceutical Benefits Advisory Committee (PBAC) guidelines review

15 September 2015 - The public submission process on the Items to be included in the PBAC Guidelines Review is now ...

Read more →

Smart buys and PBS shift pay off for Sigma

11 September 2015 - Sigma Pharmaceuticals boss Mark Hooper says the business is in a “good position”, flagging earnings growth on ...

Read more →

The life saving black magic pill that costs $140,000 a year

6 September 2015 - Matthew Fijolkowski says he wouldn’t be here today if he hadn’t got access to a miracle treatment ...

Read more →

Post-market review of authority required PBS listings

4 September 2015 - An opioids roundtable meeting was held on 27 May 2015, and an antibiotics roundtable meeting was held ...

Read more →

Update to PBS listing steps

3 September 2015 - The 'Listing Steps (Step 4)' have been updated to include an invitation for comments in relation to ...

Read more →

Update to examples for no reduction - low volume/low discount items in 'Fact Sheet - 2015 Price Disclosure Changes'

3 September 2015 - An update to the examples demonstrating application of the criteria for 'No Reduction Items - Low Volume/Low ...

Read more →

New drug listing Keytruda to treat melanoma

1 September 2015 - From today, patients with melanoma have access to breakthrough medicine Keytruda on the Pharmaceutical Benefits Scheme. ...

Read more →

Skin disease treatment now on PBS

1 September 2015 - Australians with severe psoriasis are about to have affordable access to a new medicine for the debilitating ...

Read more →

Schedule of Pharmaceutical Benefits - 1 September 2015 update

1 September 2015 - The September 2015 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. The ...

Read more →

Pembrolizumab - information for patients

1 September 2015 - Pembrolizumab has been listed on the Pharmaceutical Benefits Scheme (PBS) today via a Managed Entry Scheme (MES). ...

Read more →

Outcomes from the PBAC 2015/2 meeting

30 August 2015 - All of the outcomes from the July 2015 PBAC meeting have been entered into the MAESTrO ...

Read more →

Health officials under attack over PBS deal

28 August 2015 - Health officials have been savaged over the failure to adequately ­account for the payment of $14 billion­ ...

Read more →

Summary of the agenda for the PBAC November 2015 meeting

27 August 2015 - The PBAC will consider 69 submissions (34 major & 35 minor) at its next scheduled meeting in ...

Read more →